Cytogenetic risk explored within an electronic patient-reported outcomes (ePROs) remote symptom monitoring platform among patients with acute myelogenous leukemia (AML)
This study illustrates the feasibility of using remote symptom monitoring for evaluating patients with poor vs. other cytogenetic risk in routine care.
CareviveOctober 31, 2023